Eli Lilly and Co., US5324571083

Eli Lilly stock at EUR 1,280.60, down 0.45% premarket

Published on 11/18/2026 at 08:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Eli Lilly is a US pharmaceutical company focused on developing and commercializing medicines. On Xetra, the stock closed at EUR 1,286.40 on Tuesday, November 17, 2026.

Key points for investors

  • Eli Lilly is a US pharmaceutical company with a broad medicines portfolio.
  • The company is included in the S&P 500.
Eli Lilly and Co., US5324571083, Illustration mit AI erstellt.

Eli Lilly stock traded at EUR 1,280.60 on Lang & Schwarz at 08:11 CET on Wednesday, November 18, 2026, 0.45 percent below the Xetra close of Tuesday, November 17.

Börse Frankfurt classifies Eli Lilly as a US company in the chemicals and pharmaceuticals sector and lists the stock among the S&P 500 constituents.

Lilly remains focused on medicines

Eli Lilly develops and commercializes human medicines across its portfolio, including treatments in the diabetes and obesity markets.

The broader market context is the S&P 500.

More news and analyses on Eli Lilly and Company stock

Disclaimer...
en | US5324571083 | ELI LILLY AND CO. | boerse | 70529895 | bgmi